Pulmodual: Ipratropium bromide + Salbutamol (Pulmodual) is indicated in the treatment of reversible airways obstruction, like: asthma and Chronic Obstructive Pulmonary Disease (COPD) for patients in need of more than a single bronchodilator or who require a second bronchodilator.
Pulmodual MDI: Salbutamol Sulphate and Ipratropium Bromide Inhalation is particularly suitable for the relief and prevention of asthma systems. It should relieve symptoms when they occur and to prevent them in circumstances recognized by the patient to precipitate an asthma attack (e.g. before exercise or unavoidable allergen exposure).
Salbutamol Sulphate and Ipratropium Bromide Inhalation is particularly valuable as relief medication in mild, moderate or severe asthma, provide that reliance on it does not delay the introduction & use of regular inhaled corticosteroid therapy.
Other Services
Country
Account